ASGCT News

Non-AAV, Non-rare Gene Therapy with Derek Jackson

Listen to the latest episode of The Issue | October 15, 2024

Derek Jackson, vice president of cell and gene therapy product development at Pacira BioSciences, joins The Issue to take the program in a different direction.

Podcasts

Read Full Story

What to Know Before #ASGCTAdvancing24

There's still time to register for the Oct. 16-17 event! | October 14, 2024

Here's what you should know before attending Advancing Gene + Cell Therapies for Cancer on site in Philadelphia or virtually.

Events

Read Full Story

Networking Tips for Advancing Gene + Cell Therapies for Cancer Conference

Make the most of your time at the event with these tips. | October 14, 2024

Looking to make the most of your time at this week's conference? Here are a few easy tips to help you connect with fellow attendees.

Read Full Story

The Impact of Genetic Testing on Rare Disease Treatments

Alexis Starosta | October 07, 2024

For information about how genetic testing impacts the following conditions, check out our latest Community Quick Takes module.

Outreach

Read Full Story

Now Available: Advancing Gene + Cell Therapies for Cancer Abstracts

View and download the abstracts, and register if you haven't already! | September 30, 2024

Latest gene and cell therapy research for cancer is now available to view and download ahead of our inaugural cancer conference.

Events

Read Full Story

Feedback on FDA's Platform Technology Designation Program Includes Addressing Post-approval Changes

Andrew Liermann and Caitlin McCombs, MBA | September 23, 2024

In feedback to FDA  on its Platform Technology Designation Program, ASGCT highlighted several key areas where additional clarity and adjustments are needed, including address post-approval changes to platforms across products.

Policy & Advocacy

Read Full Story

What To Know Before the 2024 Policy Summit

You can still register to attend on site or virtually! | September 20, 2024

Here's what you should know before attending the 2024 Policy Summit at The Westin Washington, DC Downtown Hotel + virtually.

Policy & Advocacy  |  Policy Summit

Read Full Story

Next Week: Connect, Collaborate, and Innovate at the 2024 Policy Summit

Register to join us Sept. 23-24! | September 17, 2024

This 1.5 day event offers an unparalleled opportunity to engage in high-level discussions with expert presenters, gain actionable insights, and contribute to shaping the policies that will drive the future of our field.

Policy & Advocacy  |  Policy Summit

Read Full Story

The Intersection of Ethics and Gene Therapy with Dr. Ben Hurlbut

Listen to the latest episode of The Issue on the ASGCT Podcast Network. | September 17, 2024

In this episode, host Emily Walsh Martin dives into the ethical, medical, and social considerations around germline gene editing with Ben Hurlbut.

Podcasts

Read Full Story

In its Third Iteration, Biotech Discovery Labs Program Serves International Audience

Renee Strong | September 13, 2024

My experiences during BDL week this year proved to me that the impact of ASGCT’s outreach programming cannot be understated. The results may not be noticeable now but the ripple effect is happening.

Read Full Story

CRISPR Editing and AAV Integration in the Brain with Drs. Beverly Davidson and Bryan Simpson

Listen to The Molecular Therapy Podcast now! | September 10, 2024

The Molecular Therapy Podcast is back with Drs. Roland Herzog, Beverly Davidson, and Bryan Simpson.

Podcasts

Read Full Story

ASGCT Briefs Capitol Hill on Gene Therapy Breakthroughs for Hemophilia

Christina Mayer, MPA | August 30, 2024

During the briefing, experts highlighted the real-world benefits of gene therapy for hemophilia patients.

Policy & Advocacy

Read Full Story

FY25 IPPS Proposed Rule Comments Urge a Robust NTAP for All CGTs

Margarita Valdez Martínez | August 28, 2024

ASGCT supports CMS’ proposal to increase the NTAP percentage for gene therapies used to treat sickle cell disease.

Policy & Advocacy

Read Full Story

Exploring Barriers to Accessing Gene and Cell Therapy Treatments

Alexis Starosta | August 26, 2024

Our most recent Community Quick Takes module highlights access to CGTs, with speakers shedding light on critical factors that shape the field. Check it out on our Patient Education site!

Outreach

Read Full Story

Read Our Comments on FDA Guidance: Supporting Safe and Effective Cell and Gene Therapies

Andrew Liermann | August 26, 2024

ASGCT appreciates FDA’s continued efforts to streamline and accelerate the development of safe and effective new therapies. Check out this blog post summarizing two recent sets of comments.

Policy & Advocacy

Read Full Story

My Journey into Gene and Cell Therapy

Ishaku Benn Samuel, MSc, PGD (Edu), B.MLS | August 16, 2024

Learn about the experience of one of our participants in the 2023 Global Gene Therapy Training by ASGCT and Muhimbili University of Health and Allied Sciences (MUHAS).

Read Full Story